Advertisement
Persons > All
Please find below persons from Portugal and Spain and related to organsations from these countries.Total search results: 567 | Ordered by Organisation (Group) (descending)
1 2 3 4 5 6
Person | Position | Organisation (Group) | Region |
---|---|---|---|
Lippold, Marcus ([iito] Business Intelligence 2002–) | Company Founder | [iito] Business Intelligence | Bremen (federal state) |
Bailey, Mark (Zetta Genomics 202401– Board Advisor before CEO since 9/22) | Chief Executive Officer (CEO) | Zetta Genomics (Group) | East of England (region) |
Burrows, Bryony (Zetta Genomics 202304 CFO) | Chief Financial Officer (CFO) | Zetta Genomics (Group) | East of England (region) |
Medina Castello, Ignacio (Nacho) (Zetta Genomics 202402 CEO + Founder before CTO + CEO) | Chief Executive Officer (CEO) | Zetta Genomics (Group) | East of England (region) |
Sommerford, Nathan (Zetta Genomics 202307– Chief Revenue Officer formerlay at Iqvia + Roche Diagnostics) | Sales Manager / Marketing Manager | Zetta Genomics (Group) | East of England (region) |
Calzolari, Simone (ZeClinics 202102 CEO + Co-Founder) | Chief Executive Officer (CEO) | ZeClinics (ES) | Catalonia |
Garmendia, Cristina (Ysios Capital 201503 Partner) | Partner (venture partner) | Ysios Capital (Group) | Catalonia |
Harth, Thomas (Ysios Capital 202203– Principal before Senior Asociate at Gimv) | Principal (venture capital) | Ysios Capital (Group) | Catalonia |
Jean-Mairet, Joël (Ysios Capital 201206) | n. a. | Ysios Capital (Group) | Catalonia |
Lacey, David L. (Ysios Capial 201703 Venture Partner before Amgen 200705– SVP Research RETIRED before 10/12) | Venture Partner | Ysios Capital (Group) | Catalonia |
Laporta, Guillem (Ysios Capital 202007 Principal) | Investment Manager | Ysios Capital (Group) | Catalonia |
Lluís Sanfeliu, Josep (Ysios Capital Partners 201009 Partner) | Partner (venture partner) | Ysios Capital (Group) | Catalonia |
Martín-Ruiz, Raúl (Ysios Capital Partners 200809 Investment Manager) | Investment Manager | Ysios Capital (Group) | Catalonia |
Olazábal, Paula (Ysios Capital Partners 200807 Investment manager) | Investment Manager | Ysios Capital (Group) | Catalonia |
Wagner, Karen (Ysios Capital 201404 General Partner) | General Partner (venture partner) | Ysios Capital (Group) | Catalonia |
Xiol, Jordi (Ysios Capital 202112 Principal) | Principal (venture capital) | Ysios Capital (Group) | Catalonia |
Portela, Anne (Xenopat 201507 CEO + Co-founder) | Chief Executive Officer (CEO) | Xenopat (ES) | Catalonia |
Andreu Sánchez, Oscar (Xenobiotics S.L. 201504 CEO + Technical Director) | Chief Executive Officer (CEO) | Xenobiotics S.L. | Valencia (region) |
Chen, Zhisheng (Chris) (WuXi Pharmatech 201812 CEO of WuXi Biologics) | Chief Executive Officer (CEO) | WuXi PharmaTech (Group) | Jiangsu (Kiangsu) (province) |
Pascual, Carlos (Werfen 202211 CEO) | Chief Executive Officer (CEO) | Werfen (Group) | Catalonia |
Pelossof, Avi (Immucor 202211 CEO) | Chief Executive Officer (CEO) | Werfen (Group) | Georgia (state) |
Rubiralta, Marc (Werfen 202211 President) | President/Director/Head Business Group/Unit/Division | Werfen (Group) | Catalonia |
Warme, Louise (Werfen 202402 Head of We Venture Capital) | Investment Manager | Werfen (Group) | Spain_o |
Smith, Brian (Waters 200901 VP Mass Spectrometry Operations) | Business Development Manager / Strategy Manager | Waters (Group) | Massachusetts (federal state) |
Lefebvre, Gery (Wallonia (govt) 2014– Investment Manager at SRIW before Beligan Advanced Technology Systems) | Investment Manager | Wallonia (govt region) | Wallonia (region) |
Mangesius, Herbert (Vsquared Ventures 202103 Managing Partner) | Managing Partner | Vsquared Ventures (DE) | Bayern (federal state) |
Vilacoro, Antonio (Vivotecnia Research 201504 Head of Business Development) | Managing Director | Vivotecnia Research S.L. | Madrid (region) |
Ballesteros, Andrés (Vivia Biotech 201504 Managing Director) | Managing Director | Vivia Biotech S.L. | Madrid (region) |
Combal, Jean-Philippe (Vivet Therapeutics 201705 CEO + Co-Founder before Gensight Biologics + Sanofi) | Chief Executive Officer (CEO) | Vívet Therapeutics (Group) | Île-de-France (region) |
Gonzalez Aseguinolaza, Gloria (Vivet Therapeutics 201705 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vívet Therapeutics (Group) | Île-de-France (region) |
Elizalde, Natalia (ViveBiotech 202106 Business Development Director) | Chief Financial Officer (CFO) | ViveBiotech S.L. | Basque Country |
Goyena, Maider (ViveBiotech 202106 CFO) | Chief Financial Officer (CFO) | ViveBiotech S.L. | Basque Country |
Linazasoro, Gurutz (ViveBiotech 202106 CEO) | Chief Executive Officer (CEO) | ViveBiotech S.L. | Basque Country |
Asunción, Olmo (Máster Diagnóstica 201503 Technical Director) | Technical Manager | Vitro (ES) (Group) | Andalucia |
Fernández, Javier (Vitro SA 201805 CEO) | Chief Executive Officer (CEO) | Vitro (ES) (Group) | Andalucia |
Barzi, Roberto (VitaTech SA 201902 Director) | Investment Manager | VitaTech S.A. (Zambon Family + other European high-net-worth private investors) | |
Bodi, Joan (Vircell 201503 Marketing Director) | marketing | Vircell S.L. | Andalucia |
Calsada, Cris (Sanifit 201801– CFO before Ambrx + Sony Online Entertainment) | Chief Financial Officer (CFO) | Vifor Pharma (Group) | Balearic Islands |
Perelló, Joan (Sanifit 201509 CEO) | Chief Executive Officer (CEO) | Vifor Pharma (Group) | Balearic Islands |
Sánchez, Armand (Vetgenomics 201503 General Manager) | General Manager (management) | Vetgenomics S.L. | Catalonia |
Infante, Juanjo (Vaxydin 201503 CEO) | Chief Executive Officer (CEO) | Vaxydin S.L. | Andalucia |
McConell, Michael (Vaxydin 201503 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vaxydin S.L. | Andalucia |
Tabernero, Josep (Vall d’Hebron Institute of Oncology 201506 Director) | President/Director/Head of Research Organisation/Unit | Vall d’Hebron Institute of Oncology (VHIO) | Catalonia |
Albiach Martí, María R. (Valgenetics S.L. 201504 Founder+ Executive Director) | Company Founder | Valgenetics S.L. | Valencia (region) |
Lucas Martínez, Rebeca (Valentia Biopharma 201504 CEO) | Chief Executive Officer (CEO) | Valentia Biopharma S.L. | Valencia (region) |
Pérez Alonso, Manuel (Valentia Biopharma 201504 Manager+ Scientific Advisor) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Valentia Biopharma S.L. | Valencia (region) |
Uriach, Enrique (Palau Pharma 201308 Board Chairman) | Board member | Uriach (Group) | Catalonia |
Sachse, Christoph (Univ Tübingen 201504– Site Head Berlin NMI TT Pharmaservices before siTools + Cenix BioScience) | n. a. | University of Tübingen (Eberhard-Karls-Universität) | Berlin (federal state) |
Morís, Francisco (Entrechem Biotechnology 201503 Scientific Director + Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | University of Oviedo | Asturia |
Vogelmeier, Claus (Univ Gießen 201503 Professor of Internal + Respiratory Medicine) | Professor | University of Gießen (Justus Liebig University) | Hessen (Hesse) (federal state) |
Aldeguer, Xavier (Trueta Hospital 201601 Head of Digestion Unit + Co-Founder of GoodGut) | Researcher (university / research institute) | University of Gerona (UdG, University of Girona) | Catalonia |
Fernández, Irene (Univ Barcelona 201005 Head Mass Spectrometry Lab) | Head Mass Spectrometry / NMR Laboratory (university / research institute) | University of Barcelona, Mass Spectrometry Laboratory | Catalonia |
Maluquer, Salvador (Univ Barcelona 201203– General Director of Barcelona Science Park) | President/Director/Head Business Group/Unit/Division | University of Barcelona | Catalonia |
Fernández-Alba, Amadeo Rodriguez (Univ Almería 201311 Prof + EURL-FV) | Professor | University of Almería (Universidad de Almería) | Andalucia |
Fussel, Richard (United Kingdom (govt) 201311 Senior Scientist at Fera) | Researcher (university / research institute) | United Kingdom (GB) (govt) | Yorkshire and the Humber (region) |
Hsiao, Ying-Chun (TTY Biopharm 201507 Chairman) | Board member | TTY Biopharm Co. Ltd. (TWO: 4105) | Taiwan (state/region unspecified) |
Vigdor, Ran (Translational Cancer Drugs Pharma 201503 CEO) | Chief Executive Officer (CEO) | Translational Cancer Drugs Pharma, S.L. | Castila and León |
Bastian, Helge (Thermo Fisher 201406 General Manager Synthetic Biology before Indivumed + Sigma-Aldrich + SGS + Qiagen) | Managing Director | Thermo Fisher (Group) | Massachusetts (federal state) |
Matlow, Stuart (Stu) (Thermo Fisher 201206 Public Relations Manager Chromatography + Mass Spectrometry before Agilent) | Public Relations Manager / Investor Relations Manager | Thermo Fisher (Group) | California (federal state) |
Saiz-Maza, Nieves (Thermo Fisher 200803– Commercial Director Fisher Scientific Hucoa) | Sales Manager / Marketing Manager | Thermo Fisher (Group) | Madrid (region) |
Sebastian, Fernando (Thermo Fisher 200803– Managing Director Fisher Scientific Hucoa) | Managing Director | Thermo Fisher (Group) | Madrid (region) |
Silcock, Paul (Thermo Fisher 201106 GC-MS/MS Product Manager) | Product Manager (personnel) | Thermo Fisher (Group) | Massachusetts (federal state) |
Passarell, Rosa (Tecil 201510 Scientific Advisor working at Tecil since 1988) | cystic fibrosis | Tecil (ES) | Catalonia |
Salaverría, Julia (Talde Gestión SGECR S.A. 200803 Former Fund Manager) | Managing Partner | Talde Gestión, SGECR, S.A. | Basque Country |
Zalbidegottia, José María ( Talde Gestión, SGECR S.A. 201504 Chairman) | Managing Director | Talde Gestión, SGECR, S.A. | Basque Country |
Bravo, Eduardo (Life Sciences Partners 202103– Partner + CEO of EBAC before Nordic Nanovector + TiGenix + Cellerix) | Chief Executive Officer (CEO) | Takeda (Group) | Belgium_o |
Gerson, Miles (Takeda 202004– Senior Investment Director at Takeda Ventures Inc before miRagen Therapeutics) | Investment Manager | Takeda (Group) | California (federal state) |
Nüsslein-Vollhard, Christiane | n. a. | Taconic (Group) | Nordrhein-Westfalen (federal state) |
Hagen, Alexander (Synlab 201603 Group Head of Marketing + Communications) | Sales Manager / Marketing Manager | Synlab (Group) | Bayern (federal state) |
Valor, Santiago (Synlab 201603 CMO) | Chief Medical Officer (CMO) | Synlab (Group) | Bayern (federal state) |
Díaz, Carlos (Synapse Research Management Partners 201503 CEO + Founder) | Chief Executive Officer (CEO) | Synapse Research Management Partners SL | Catalonia |
Molero, Eva (Synapse Research Management Partners 201503 CEO + Founder) | Chief Executive Officer (CEO) | Synapse Research Management Partners SL | Catalonia |
Oelkers, Guido (Swedish Orphan Biovitrum 201705– CEo before BSN Medical GmbH + Nycomed) | Chief Executive Officer (CEO) | Swedish Orphan Biovitrum (Sobi) (Group) | Stockholm (region) |
Garcia Martin, Angel (StemTek Therapeutics SL 201509 CEO) | Chief Executive Officer (CEO) | StemTek Therapeutics S.L. | Spain_o |
Leis Esnaola, Olatz (Stem Tek Therapeutics 201503 CEO) | Chief Executive Officer (CEO) | Stem Tek Therapeutics S.L | Basque Country |
Llull, Ramón (Stem Center 201503 Director) | Managing Director | Stem Center S.L.U. | Balearic Islands |
Durham, Lynn-Allison (Stalicla 2017– CEO + Founder) | Chief Executive Officer (CEO) | Stalicla S.A. | Région Lémanique (region) |
Hyvelin, Jean-Marc (Stalicla 202002 COO) | Chief Operating Officer (COO) | Stalicla S.A. | Région Lémanique (region) |
Tuncer, Özgür (Stablepharma 202212 CEO) | Chief Executive Officer (CEO) | Stablepharma (Group) | South West England (region) |
Caelles, Gerard (SpliceCio 202202 CBO) | Chief Business Officer (CBO) | SpliceBio S.L. | Catalonia |
Vila-Perelló, Miquel (SpliceBio 202009 CEO + Co-Founder) | Chief Executive Officer (CEO) | SpliceBio S.L. | Catalonia |
Amat Riera, Jaume (Specific Pig 202203 CEO) | Chief Executive Officer (CEO) | Specific Pig S.L. (Specipig) | Catalonia |
Bosch, Assela (Specific Pig 202203 Business Development Manager) | Business Development Manager / Strategy Manager | Specific Pig S.L. (Specipig) | Catalonia |
Rial, Maria Àngels (Specific Pig 201503 President + Founder) | President/Director/Head Business Group/Unit/Division | Specific Pig S.L. (Specipig) | Catalonia |
Montagner, Carlo (200801– CEO + Founder of STA before Alchemia + Abraxas Bioscience et al + Schering 200510) | Chief Executive Officer (CEO) | Specialised Therapeutics Australia Pty Ltd. (STA) | Victoria (VIC) |
Calleja, Montserrat (CSIC 201302 Dept Head at Bionanomechanics lab at IMM) | Researcher (university / research institute) | Spain (govt) | Madrid (region) |
Sanz, Yolanda (Univ Valencia + IATA + MyNewGut project) | Professor | Spain (govt) | Valencia (region) |
Casoliva, Oriol (i-Dositecno 201910 CEO + Founder) | Chief Executive Officer (CEO) | SP Industries (Group) | Catalonia |
Larkin, Brian (SP Industries 201910 CEO) | Chief Executive Officer (CEO) | SP Industries (Group) | Pennsylvania (federal state) |
Whitehall, Ian (SP Industries 201910 Chief Marketing Officer) | Chief Commercial Officer (CCO) | SP Industries (Group) | Pennsylvania (federal state) |
Althoff, Gioia (Sophia Genetics 201904 SVP Genomics) | President/Director/Head Business Group/Unit/Division | Sophia Genetics (Group) | Région Lémanique (region) |
Casellas, Marc (SOM Biotech 202106– CFO before Ysios Capital Partners + Danone Group + PwC Consulting) | Chief Financial Officer (CFO) | SOM Innovation Biotech S.L. (SOM Biotech) | Catalonia |
Insa, Raúl (SOM Biotech 201211 CEO) | Chief Executive Officer (CEO) | SOM Innovation Biotech S.L. (SOM Biotech) | Catalonia |
Ciruelos, Eva (SOLTI 201610 President) | President/Director/Head of Research Organisation/Unit | SOLTI (ES) | Catalonia |
Irigoien, Pilar (Navarra (govt) 201907 General Manager of Sodena) | General Manager (management) | Sodena (Sociedad de Desarrollo de Navarra) S.L. | Navarre (Navarra) |
Gil Redondo, Rubén (Smartligs Bioinformática 201504 Co-founder + CEO) | Chief Executive Officer (CEO) | Smartligs Bioinformática S.L. | Madrid (region) |
Benítez Ortiz, Javier (Sistemas Genómicos 201504 Foundation Chair and Advisor) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Sistemas Genómicos S.L. | Valencia (region) |
Manent, Jose (Sinoptia 201503 President) | President/Director/Head Business Group/Unit/Division | Sinoptia S.L. | Catalonia |
Drejer, Kirsten (Symphogen 2000–201608 Founding CEO since 201609 Executive Director) | Board member, executive | Servier (Group) | Denmark_o |
Nicaise, Claude (Sarepta 201702 Board Member + Mynoryx Board Member before Alexion 1983–2008 + BMS 1983-2008) | Board member, non-executive | Sarepta Therapeutics Inc. (NASDAQ: SRPT) | Massachusetts (federal state) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top